Clinical trial
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
NCT00970203
Study timeline
Study start (unknown)2009-09-01Date precision: month
Registry last updated2020-11-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cancer of Prostateunresolved
Cancer of the Prostateunresolved
Neoplasms, Prostateunresolved
Neoplasms, Prostaticunresolved
Prostate Cancerunresolved
Prostate Neoplasmsunresolved
Prostatic Cancerunresolved
Interventions
androgen ablation (AA)BIOLOGICAL
DC1 vaccineBIOLOGICAL
Sponsors & collaborators
Roswell Park Cancer Institutelead sponsor
University of Pittsburghcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00970203 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.